Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 19.37% is 41% above its 5-year average of 13.71%, near the high end of its 5-year range (7.56%–19.66%).
As of the fiscal period ended Tuesday, June 30, 2026. 33.66% above its 12-month average of 14.49%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
19.37%
NET PROFIT MARGIN AVG TTM
14.49%
NET PROFIT MARGIN AVG 3Y
13.86%
NET PROFIT MARGIN AVG 5Y
13.71%
NET PROFIT MARGIN AVG 10Y
13.84%
NET PROFIT MARGIN AVG 15Y
13.93%
NET PROFIT MARGIN AVG 20Y
14.60%
CURRENT VS TTM AVG
+33.66%
CURRENT VS 3Y AVG
+39.68%
CURRENT VS 5Y AVG
+41.20%
CURRENT VS 10Y AVG
+39.94%
CURRENT VS 15Y AVG
+39.05%
CURRENT VS 20Y AVG
+32.68%
SECTOR MEDIAN · HEALTHCARE
9.05%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+113.98%
vs the sector median at left
Stryker Corporation
Market Cap
$124.86B
Net Profit Margin
19.37%
TTM Avg
14.49%
3Y Avg
13.86%
5Y Avg
13.71%
Market Cap
$124.82B
Net Profit Margin
28.45%
TTM Avg
28.09%
3Y Avg
25.67%
5Y Avg
26.14%
Market Cap
$121.09B
Net Profit Margin
35.40%
TTM Avg
13.94%
3Y Avg
25.44%
5Y Avg
29.40%
Market Cap
$131.47B
Net Profit Margin
17.19%
TTM Avg
15.23%
3Y Avg
12.72%
5Y Avg
10.53%
Market Cap
$133.37B
Net Profit Margin
18.87%
TTM Avg
-1.95%
3Y Avg
6.91%
5Y Avg
3.59%
Market Cap
$137.13B
Net Profit Margin
15.95%
TTM Avg
15.52%
3Y Avg
19.51%
5Y Avg
19.37%
Market Cap
$109.30B
Net Profit Margin
13.20%
TTM Avg
13.55%
3Y Avg
12.62%
5Y Avg
13.06%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | $124.86B | 19.37% | 14.49% | 13.86% | 13.71% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 28.45% | 28.09% | 25.67% | 26.14% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 35.40% | 13.94% | 25.44% | 29.40% |
| AstraZeneca PLC (AZN)vs › | $131.47B | 17.19% | 15.23% | 12.72% | 10.53% |
| CVS Health Corp. (CVS)vs › | $133.25B | 0.72% | 0.84% | 1.34% | 1.79% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 18.87% | -1.95% | 6.91% | 3.59% |
| Danaher Corporation (DHR)vs › | $137.13B | 15.95% | 15.52% | 19.51% | 19.37% |
| Medtronic plc (MDT)vs › | $109.30B | 13.20% | 13.55% | 12.62% | 13.06% |
| Pfizer Inc. (PFE)vs › | $142.54B | 11.83% | 12.51% | 14.97% | 18.18% |
| GSK plc (GSK)vs › | $103.56B | 17.76% | 12.86% | 23.24% | 22.39% |
Operating Margin
22.0%
Net Profit Margin
19.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 19.37% |
| 2026-03-31 | 12.38% |
| 2025-12-31 | 11.84% |
| 2025-09-30 | 14.18% |
| 2025-06-30 | 14.68% |
| 2025-03-31 | 11.15% |
| 2024-12-31 | 8.48% |
| 2024-09-30 | 15.18% |
| 2024-06-30 | 15.22% |
| 2024-03-31 | 15.03% |
| 2023-12-31 | 19.66% |
| 2023-09-30 | 14.10% |
| 2023-06-30 | 14.77% |
| 2023-03-31 | 12.39% |
| 2022-12-31 | 10.82% |
| 2022-09-30 | 18.22% |
| 2022-06-30 | 14.60% |
| 2022-03-31 | 7.56% |
| 2021-12-31 | 14.08% |
| 2021-09-30 | 10.53% |
| 2021-06-30 | 13.79% |
| 2021-03-31 | 7.64% |
| 2020-12-31 | 13.33% |
| 2020-09-30 | 16.62% |
| 2020-06-30 | -3.00% |
| 2020-03-31 | 13.74% |
| 2019-12-31 | 17.55% |
| 2019-09-30 | 12.99% |
| 2019-06-30 | 13.15% |
| 2019-03-31 | 11.72% |
| 2018-12-31 | 54.48% |
| 2018-09-30 | 18.20% |
| 2018-06-30 | 13.61% |
| 2018-03-31 | 13.67% |
| 2017-12-31 | -7.17% |
| 2017-09-30 | 14.44% |
| 2017-06-30 | 12.98% |
| 2017-03-31 | 15.03% |
| 2016-12-31 | 16.15% |
| 2016-09-30 | 12.53% |
| 2016-06-30 | 13.38% |
| 2016-03-31 | 16.11% |
| 2015-12-31 | 19.23% |
| 2015-09-30 | 12.44% |
| 2015-06-30 | 16.12% |
| 2015-03-31 | 9.42% |
| 2014-12-31 | 9.93% |
| 2014-09-30 | 2.39% |
| 2014-06-30 | 9.10% |
| 2014-03-31 | 3.04% |
| 2013-12-31 | 15.64% |
| 2013-09-30 | 4.79% |
| 2013-06-30 | 9.63% |
| 2013-03-31 | 13.88% |
| 2012-12-31 | 11.55% |
| 2012-09-30 | 17.20% |
| 2012-06-30 | 15.43% |
| 2012-03-31 | 16.20% |
| 2011-12-31 | 18.10% |
| 2011-09-30 | 16.10% |
| 2011-06-30 | 15.16% |
| 2011-03-31 | 15.23% |
| 2010-12-31 | 14.79% |
| 2010-09-30 | 19.07% |
| 2010-06-30 | 18.14% |
| 2010-03-31 | 17.88% |
| 2009-12-31 | 16.68% |
| 2009-09-30 | 13.85% |
| 2009-06-30 | 17.82% |
| 2009-03-31 | 17.55% |
| 2008-12-31 | 16.16% |
| 2008-09-30 | 16.56% |
| 2008-06-30 | 17.86% |
| 2008-03-31 | 17.77% |
| 2007-12-31 | 16.65% |
| 2007-09-30 | 15.74% |
| 2007-06-30 | 34.79% |
| 2007-03-31 | 16.24% |
| 2006-12-31 | 15.58% |
| 2006-09-30 | 14.45% |
| 2006-06-30 | 16.11% |
| 2006-03-31 | 11.17% |
| 2005-12-31 | 14.52% |
| 2005-09-30 | 10.30% |
| 2005-06-30 | 14.59% |
| 2005-03-31 | 14.40% |
| 2004-12-31 | 14.08% |
| 2004-09-30 | 1.40% |
| 2004-06-30 | 14.64% |
| 2004-03-31 | 13.13% |
| 2003-12-31 | 13.39% |
| 2003-09-30 | 12.18% |
| 2003-06-30 | 12.06% |
| 2003-03-31 | 12.29% |
| 2002-12-31 | 12.80% |
| 2002-09-30 | 9.72% |
